NasdaqGS:IDXXMedical Equipment
IDEXX (IDXX) Stock Looks Undervalued On Cash Flow While Earnings Look Overvalued
IDEXX Laboratories stock is caught between a discounted intrinsic value estimate and a richer market pricing, with the Discounted Cash Flow (DCF) work suggesting about 10.7% upside while traditional multiples point to an overvalued profile and a low overall value score.
Over the past 5 years, IDEXX Laboratories has delivered a decline of 21.6%, which makes the current valuation especially important for investors who have sat through a weak longer term return.
Recent commentary around...